AUPH.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

Stock prediction for AUPH.US - Aurinia Pharmaceuticals

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. The company also offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

symbol	last	change	%chng	name	mcap	sector	wiki
AUPH				Aurinia Pharmaceuticals Inc	1.286B	Healthcare

	symbol	prev.close	range	chart	target	percent	period	months	due	rating
D	AUPH	8.86	0,-2.036,0.954,-0.337,-2.036	9.88,9.18,8.38,7.98,7.30,7.45,7.68,7.33,7.59,7.99,8.18,9.05,8.71,8.82	4.38-6.97	-35.96%	267,67,267	6.7	Oct 5-Jun 28	38.58%

stock prediction graph

prediction values

stock	low target	target	high target	to go	days	target date
AUPH	4.38	5.67	6.97	-42.82%	267	Jun 28
AUPH	5.04	6.10	7.16	-37.08%	177	Mar 30
AUPH	5.19	6.20	7.22	-35.73%	167	Mar 20
AUPH	5.26	6.23	7.20	-35.35%	157	Mar 10
AUPH	5.40	6.32	7.25	-34.11%	147	Feb 29
AUPH	5.49	6.40	7.30	-33.10%	137	Feb 19
AUPH	5.66	6.49	7.33	-31.82%	127	Feb 9
AUPH	5.72	6.51	7.31	-31.57%	117	Jan 30
AUPH	5.86	6.60	7.34	-30.33%	107	Jan 20
AUPH	5.94	6.63	7.32	-29.94%	97	Jan 10

``` ```